Studies - Copper Inside

Studies

Cosmetics

Expert Opinion

International J. of Cosmetic Science - 2009

JCD 2012

Skin Lifting - 2016

Using Copper to Improve the Well-Being of the Skin - 2014

Covid-19 Studies

Anti Viral influenza Study - PLoS ONE article (2010)

Copper-oxide impregnated respiratory masks may (Research Square) Study Whitepaper

SARS-Cov-2 Test Report Hong Kong University

Whitepaper - Copper Oxide Kill the COVID-19

EN14683

Testrapport – undersøkelse av medisinske ansiktsmasker (EN 14683)

Testrapport – undersøkelse av medisinske ansiktsmasker (EN 14683)

Testrapport – undersøkelse av medisinske ansiktsmasker (EN 14683)

Whitepaper - Copper Oxide Kill the COVID-19

Multiuse

Copper inside – study report

MedCu Mask 7 multiple inoculations Laboratory test report - White paper

Multiuse

FOOT ms - 2008

Herzog manuscript -HAI - 2017

IJID - Reuth NI Study - 2014

Military Technology ms - 2013

Safety of Using Diapers Containing Copper Oxide in Chronic Care Elderly Patients - 2013

Safety-of-Copper-Oxide - Bibliography of scientific studies

Sentara 6 hospitals Linen only 2018

Sentara Study - 2016

Skin Surface Elasticity - 2014

Socks - Large Scale survey - 2017

TOBIOJ sock ms - 2012

WOUNDS ms - 2010

Fabrics tested against SARS-CoV-2-2 30.6.20

Info & service

Partners | Support | Terms & Conditions | Privacy Policy

Terms & Conditions

About us

Israeli Copper Inside Mask material is produced from a tiny amount of copper particles CU2O which are blended during the development of polymers.
The raw material for the masks produced in Israel, embeds various copper formulations in select polymers that enable finished products to deliver the desired impact.

Contact us

Subscribe for more info:

The product has been authorized by the FDA under an EUA for use as source control by the general public as well as by health care professionals in healthcare settings as to help prevent the spread of infection or illness during the COVID-19 pandemic, per r section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1) and it is not been cleared or approved.